文献速递临床生化质量管理与危急值

儿科肾素样本测定的持续方法性能监测:欧洲临床试验中的应用

A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial.
PubMed 文献 · Clin Chem Lab Med · 2020-01-01

在LENA项目中建立了一套符合法规的生化分析质量控制(QC)概念,涵盖系统适用性测试、单批校准与QC评价、批间准确度评估、儿科实际样本重现性监测、空白样本分析和实验室间比对。约11%的单批被判定无效并触发再分析,147对再分析实际样本均符合法规要求,最终可靠定量了965份儿科肾素样本。

要点

  • 约11%的单批被判定无效并触发未知样本再分析。
  • 147对再分析实际样本均符合法规要求。
  • 该QC概念可靠定量了965份儿科肾素样本。

核心结论

  • 为学术驱动的儿科试验定制的合规QC概念有助于儿科肾素样本的可靠定量。

研究设计与样本

  • 在LENA项目中设计QC概念,涵盖法规指导、国际建议和当前科学讨论。
  • QC概念包括系统适用性测试、单批校准曲线性能与QC评价、按CLSI指南评估批间准确度、儿科实际样本重现性监测、空白样本分析和实验室间比对。

主要发现

  • 约11%的单批被识别为无效并触发再分析。
  • 定制的批间监测证明了从首批到末批的良好准确度。
  • 147对再分析实际样本均符合法规要求。
  • 最终可靠定量了965份儿科肾素样本。

关键数值与推荐

  • 批间准确度按CLSI指南评估。

临床怎么用

  • 在学术驱动的儿科试验中采用包含系统适用性、单批校准与QC评价、批间准确度、实际样本重现性、空白分析和实验室间比对的QC概念监测方法性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Plasma renin levels were determined in the academia-driven, EU-funded "Labeling of Enalapril from Neonates up to Adolescents" (LENA) project to evaluate its role in pediatric heart failure. Quality-controlled bioanalysis is crucial to ensure reliable data generation. However, a comprehensive bioanalytical quality control (QC) concept to monitor the method performance within an academic environment was lacking. Methods Thus, a QC concept was designed encompassing regulatory guidance, international recommendations and current scientific discussions. The concept included (1) a system-suitability test, (2) verification of single bioanalytical runs by calibration curve performance and evaluation of QCs, (3) assessment of the inter-run accuracy according to Clinical Laboratory Standards Institute (CLSI) guideline, (4) monitoring of reproducibility by pediatric incurred samples, (5) blank-sample analysis and (6) participation in interlaboratory testing. Results The concept was successfully applied to the academic project. About 11% of single runs were identified as invalid and triggered a re-analysis of unknown samples being included in those runs. The usefulness of the customized inter-run monitoring was demonstrated and proved the good accuracy from the first to the last run. All 147 reanalyzed incurred sample pairs complied with regulatory requirements. Conclusions The regulatory complied QC concept was customized for the demands of academia-driven pediatric trials and contributed to the reliable quantification of 965 pediatric renin samples.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Feickert M, Burdman I, Makowski N, et al. A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial. Clin Chem Lab Med. 2020. PMID: 32049647. doi:10.1515/cclm-2019-1162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。